6
Oct
2026

Symeres

Exhibitor at CPHI Milan 2026 stand 12F38, Contract Manufacturing & Services
About Us

Symeres is your CDMO that turns small-molecule ideas into clinical candidates. We work across medicinal chemistry, in vitro biology, ADME-Tox, & process chemistry to move compounds forward, even when biology doesn’t behave. You’ll always know what’s working, what’s not, and what to do next

We reduce that risk by keeping discovery, development and manufacturing connected. We share results fast so you can adapt quickly and keep moving. 

Hit Finding | Hit to Lead | Lead Optimization | Preclinical Development | Clinical Development

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Netherlands
  • On CPHI since:
    2021
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 12F38, Contract Manufacturing & Services

Products Featured at CPHI Milan 2026

  • Formulation Development and Clinical Manufacturing

    Product Formulation Development and Clinical Manufacturing

    We blend the art of formulation with advanced scientific tools to support drug product development from early stages through Phase 3, offering comprehensive manufacturing and regulatory services. It is often said that formulation is an art, not a science. Our art is supported by an extensive array of scie...
  • GMP Manufacturing

    Product GMP Manufacturing

    Close collaboration with our experienced process engineers aid our efforts achieve right first time scale-up of processes for GMP manufacture. The processes developed at our facilities are adapted to the plant environment in close collaboration with experienced process engineers. The limits of operating c...
  • Non-GMP scale-up for IND-enabling studies

    Product Non-GMP scale-up for IND-enabling studies

    Symeres has long-established expertise in non-GMP scale-up for IND-enabling studies, ensuring that our clients can confidently navigate the transition from laboratory-scale synthesis to clinical phases while minimizing costs and risks. The well-documented processes we provide significantly reduce the inh...
  • Route Scouting for challenging APIs

    Product Route Scouting for challenging APIs

    Symeres is well equipped to ideate around your challenging small molecule APIs
  • Solid-State Chemistry and Pre-Formulation Research

    Product Solid-State Chemistry and Pre-Formulation Research

    Our Solid-State experts can help you to selectively crystallize the optimal stable form and formulate your compound. A controlled crystallization is the preferred isolation method to obtain purified material of a specific polymorphic (salt) form and crystal habit. The solid form determines the stability, ...

Symeres Resources (1)

  • Drug Development

    Brochure Drug Development

    Leverage our 30+ years of experience to design your optimal drug route, with seamless transition to our non-GMP or GMP scale-up units.